KGK Insights Blog

  • 4th Annual IPA Probiotics Workshop: Q&A with KGK CEO Najla Guthrie and George Paraskevakos of IPA

    Posted on Wed, 30 Oct 2019 by KGK Science in: All News0 Comments

    As the title sponsor for the 4th Annual IPA Probiotics Workshop in DC, KGK Science President & CEO, Najla Guthrie got together with IPA Executive Director, George Paraskevakos for a Q&A to discuss the days events.

    View Full Article ›

  • Are Your Cannabis Edibles Set Up for Sweet Success?

    Posted on Thu, 17 Oct 2019 by KGK Science in: All News0 Comments

    With the new regulations and guidelines surrounding cannabis edibles, it can be difficult to know exactly how to formulate, package, and test them to ensure successful market entry and customer satisfaction. KGK Science can help.

    View Full Article ›

  • KGK Goes Big on Scientific and Regulatory Expertise at NPA’s The Big Natural Show

    Posted on Wed, 18 Sep 2019 by KGK Science in: All News0 Comments

    Crucial conversations took place at NPA's The Big Natural and Natural Products Day in Washington, D.C., including advocacy for safety and increased regulation.

    View Full Article ›

  • The 2018 Farm Bill and the Legality of CBD in the United States

    Posted on Wed, 20 Feb 2019 by Andrew Charrette, Senior Manager, Regulatory Affairs in: All News0 Comments

    The 2018 Farm Bill was passed on December 20, 2018, and initiated a paradigm shift in the way that hemp and its derivatives are viewed in the US.

    View Full Article ›

  • I’d Like to Conduct Research on My Product. What Now?

    Posted on Mon, 04 Mar 2019 by KGK Science in: All News0 Comments

    Although conducting a clinical trial may seem like a daunting and expensive task, it’s an important investment that will have a substantial return in the product’s life-cycle.

    View Full Article ›

  • Shifting Paradigms: Discussing the State of Global Health Care with Dr. Mal Evans

    Posted on Fri, 17 May 2019 by Dr. Mal Evans, Chief Science Officer, KGK Science in: All News0 Comments

    Dr. Mal Evans, our CSO, recently spoke at a symposium for the Munk School of Global Affairs & Public Policy. Prospects for Japan’s G20 Osaka Summit provided a critical assessment of the agenda for the upcoming G20 event.

    View Full Article ›

  • Budding Research: Conducting Clinical Cannabis Trials in Canada

    Posted on Thu, 30 May 2019 by Andrew Charrette, Senior Manager, Regulatory Affairs in: All News0 Comments

    While Canada itself is a wonderful environment in which to study cannabis, KGK takes it one step further.

    View Full Article ›

  • Is the Industry’s Insight into CBD Half-Baked?

    Posted on Wed, 19 Jun 2019 by Najla Guthrie, President & CEO, KGK Science in: All News0 Comments

    This month, as part of the “early stages” of its establishment of regulatory guidelines for Cannabidiol (CBD), the US Food and Drug Administration (FDA) held its first-ever public hearing on the subject.

    View Full Article ›

  • What’s Coming Down the Pipe for Cannabis Research?

    Posted on Tue, 25 Jun 2019 by Joseph Antony, PhD, KGK Science in: All News0 Comments

    As our pursuit of cannabis knowledge continues to hasten, a large crop of innovative and interesting studies are sure to arise. But what should this novel research explore? How can we improve our investigative processes?

    View Full Article ›

  • Get the Scoop on Synbiotics

    Posted on Tue, 25 Jun 2019 by Joseph Antony, PhD, KGK Science in: All News0 Comments

    It’s no secret that dietary fibre and probiotics are both vital in the enhancement and maintenance of a healthy digestive system. However, the power they hold when united is lesser understood: together, they may greatly improve gut function.

    View Full Article ›

  • Regulatory Developments in the Cannabiz

    Posted on Tue, 25 Jun 2019 by Andrew Charrette, Senior Manager, Regulatory Affairs in: All News0 Comments

    An update on the evolving rules and regulations surrounding cannabis in Canada and the U.S.

    View Full Article ›

  • CBD and the Microbiome

    Posted on Wed, 03 Apr 2019 by Joseph Antony, PhD, KGK Science in: All News0 Comments

    The microbiome in the human gut measures 100 trillion microorganisms, exceeding the human cell count 100-fold. How is this altered by THC and CBD?

    View Full Article ›

Request a Quote

Fill in our simple online form and we will contact you back to discuss your requirements.

Request Quote

Twitter

Subscribe to our E-Newsletter

Sign up here to receive the latest news from KGK Science.

Subscribe To KGK Science